Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Binge-Eating Disorder: early-phase trial registry
17 of 39 indexed Binge-Eating Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #382 of 28,707 conditions by registered trial count.
39 US clinical trials · 17 currently recruiting · #382 of 28,707 conditions by registered trial count
Binge-Eating Disorder: 39 US clinical trials tracked, 17 recruiting.
Binge-Eating Disorder is the subject of 39 registered US clinical trials on ClinicalTrials.gov, 17 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 6 of these trials.
Enrollment posture brief
Registry condition binge-eating-disorder
OPEN 17 | RECR 44% | LATE 4 | EARLY 10 | RANK #382 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Traumatic Brain Injury (44% recruiting · 172 trials)
Binge-Eating Disorder lists 17 open slots (44% of 39 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Binge-Eating Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Binge-Eating Disorder is recruiting above its size-band peers.
17 of 39 indexed trials (43.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Binge-Eating Disorder research.
Yale University accounts for 6 of 39 trials (15.4%). 26 distinct sponsors appear on at least one study for this condition label.
-
Most Binge-Eating Disorder trials plan to enrol fewer than 100 people.
Median target enrolment is 76 among the 38 trials that report a genuine target (sentinel values excluded). 23 of those (60.5%) plan for fewer than 100 participants.
-
Binge-Eating Disorder research is mostly interventional.
36 interventional and 3 observational studies make up this index (92.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
39 total, page 1 of 1
Eating Disorders Genetics Initiative 2
University of North Carolina, Chapel Hill
NCT06594913
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Axsome Therapeutics
NCT06413433
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Drexel University
NCT05473013
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
Duke University
NCT05540704
Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids
University of Pittsburgh
NCT04701671
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
VA Connecticut Healthcare System
NCT05304104
Project VIBE: Virtual Intervention for Binge Eating in Adolescents
University of Pittsburgh
NCT06819813
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
Johns Hopkins University
NCT06847399
Preventing Type 2 Diabetes in Black Emergent Adult
University of North Carolina, Chapel Hill
NCT06848244
Building Healthy Eating and Self-Esteem Together for University Students
University of Kansas
NCT07060534
Treating Binge Eating and Obesity Digitally in Black Women
University of North Carolina, Chapel Hill
NCT05693896
A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder
Massachusetts General Hospital
NCT05664516
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
Icahn School of Medicine at Mount Sinai
NCT06858774
Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder
Yeshiva University
NCT07212673
A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity
Drexel University
NCT06817863
Relationships Between Exercise and Appetite in Women With Loss of Control Eating
Ohio University
NCT06602973
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
Milton S. Hershey Medical Center
NCT07237607
Effects of Negative Affect in Individuals With Binge Eating Episodes
University of California, San Diego
NCT03393039
Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating
Drexel University
NCT05937243
Low Intensity Focused Ultrasound for Binge Eating Disorder
Ali Rezai
NCT06485687
Eating Disorders Genetics Initiative
University of North Carolina, Chapel Hill
NCT04378101
Open Label Extension in Adults With Binge Eating Disorder (BED)
Shire
NCT01657019
Dasotraline Binge Eating Disorder Study
Sumitomo Pharma America
NCT02564588
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment
Yale University
NCT03924193
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
Yale University
NCT03045341
Integrative Cognitive-Affective Therapy for Binge Eating Disorder
University of Minnesota
NCT02043496
Appetite Hormones in Binge Eating Disorder
New York Obesity and Nutrition Research Center
NCT01552759
Vortioxetine for Binge Eating Disorder
University of Chicago
NCT02528409
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
Alkermes
NCT01098435
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
Yale University
NCT03047005
Craving, Binge Eating and Obesity
Yale University
NCT00414167
The Role of the Circadian System in Binge Eating Disorder
University of Cincinnati
NCT04724668
Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder
University of Pennsylvania
NCT03604172
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
Yale University
NCT03063606
Engaging Latino Families in Eating Disorders Treatment
Mae Lynn Reyes-Rodriguez, PhD
NCT01470508
Project BITE: Binge Intervention Target Effectiveness
Drexel University
NCT03113669
Uniting Couples In the Treatment of Eating Disorders (UNITE)
University of North Carolina, Chapel Hill
NCT02419326
Binge Eating Self-help for Teens ONLINE Pilot and Feasibility Study
Yale University
NCT06107387
Atomoxetine in the Treatment of Binge Eating Disorder
Lindner Center of HOPE
NCT00327834
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 9 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Binge-Eating Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Binge-Eating Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Binge-Eating Disorder page
39 registered trials, 17 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 17 Binge-Eating Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Yale University sponsors the most Binge-Eating Disorder trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Binge-Eating Disorder condition card totals 39 registered trials; most-linked intervention Placebo; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.